The next era of gene-specific clinical care in patients with dilated cardiomyopathy

Job A J Verdonschot^{1

2

3}, Stephane R B Heymans^{1

3

4}, Sophie Van Linthout^{5

6}

Affiliations

¹ Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
² Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
³ European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart).
⁴ Centre of Cardiovascular Research, Centre for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
⁵ Berlin Institute of Health (BIH) at Charité - University Medicine Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.
⁶ DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Free article

Editorial

Job A J Verdonschot et al. Eur J Heart Fail. 2024 Oct.

Free article

. 2024 Oct;26(10):2169-2172.

doi: 10.1002/ejhf.3446. Epub 2024 Sep 1.

Job A J Verdonschot^{1

2

3}, Stephane R B Heymans^{1

3

4}, Sophie Van Linthout^{5

6}

¹ Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
² Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
³ European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart).
⁴ Centre of Cardiovascular Research, Centre for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
⁵ Berlin Institute of Health (BIH) at Charité - University Medicine Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.
⁶ DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.

No abstract available

References

1. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales‐Villa R, Basso C, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023;44:3503–3626. https://doi.org/10.1093/eurheartj/ehad194
1. Verdonschot JAJ, Hazebroek MR, Krapels IPC, Henkens MTHM, Raafs A, Wang P, et al. Implications of genetic testing in dilated cardiomyopathy. Circ Genom Precis Med 2020;13:476–487. https://doi.org/10.1161/CIRCGEN.120.003031
1. Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, et al. Evidence‐based assessment of genes in dilated cardiomyopathy. Circulation 2021;144:7–19. https://doi.org/10.1161/CIRCULATIONAHA.120.053033
1. Anastasiou V, Papazoglou AS, Gossios T, Zegkos T, Daios S, Moysidis DV, et al. Prognostic implications of genotype findings in non‐ischemic dilated cardiomyopathy: A network meta‐analysis. Eur J Heart Fail 2024;26:2155–2168. https://doi.org/10.1002/ejhf.3403
1. Wahbi K, Ben Yaou R, Gandjbakhch E, Anselme F, Gossios T, Lakdawala NK, et al. Development and validation of a new risk prediction score for life‐threatening ventricular tachyarrhythmias in laminopathies. Circulation 2019;140:293–302. https://doi.org/10.1161/CIRCULATIONAHA.118.039410